Michał Gil
6PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 14, 2025
Effectiveness of First-Line Treatment with Anaplastic Lymphoma Kinase and ROS1 Protoncogene Inhibitors in Non-Small Cell Lung Cancer Patients-Real-World Evidence of Two Polish Cancer Centers.Michał Gil, Kinga Winiarczyk, Paweł Krawczyk
|Nov 07, 2024
Exploring immunotherapy efficacy in non-small cell lung cancer patients with <i>BRAF</i> mutations: a case series and literature review.Izabela Chmielewska, Paweł Krawczyk, Magdalena Wójcik-Superczyńska
|Jul 29, 2023
Breaking the 'Undruggable' Barrier: Anti-PD-1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer Patients with <i>KRAS</i> Mutations-A Comprehensive Review and Description of Single Site Experience.Izabela Chmielewska, Paweł Krawczyk, Anna Grenda
|Mar 10, 2023
Effectiveness of ALK inhibitors in treatment of CNS metastases in NSCLC patients.Michał Gil, Magdalena Knetki-Wróblewska, Przemysław Niziński
|Oct 23, 2021
Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement.Paweł Krawczyk, Anna Grenda, Paulina Terlecka
|Jul 02, 2021
Two Complementarity Immunotherapeutics in Non-Small-Cell Lung Cancer Patients-Mechanism of Action and Future Concepts.Kamila Wojas-Krawczyk, Paweł Krawczyk, Michał Gil
Pageof 1
Frequent Collaborators
3 joint publications
Kamila Wojas-Krawczyk
3 joint publications
Maciej Strzemski
3 joint publications
Izabela Chmielewska
2 joint publications
Paweł Krawczyk
2 joint publications
Anna Grenda
2 joint publications
Robert Kieszko
2 joint publications
Janusz Milanowski
1 joint publications
Paulina Terlecka
1 joint publications
Justyna Błach
1 joint publications
Tomasz Kucharczyk
